Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
02 2022
Historique:
revised: 29 04 2021
received: 04 01 2021
accepted: 02 05 2021
pubmed: 27 7 2021
medline: 26 4 2022
entrez: 26 7 2021
Statut: ppublish

Résumé

No large-scale characterizations of neurofilament light chain (NfL) have been conducted in diverse populations. Baseline data were analyzed among n = 890 Mexican Americans and n = 813 non-Hispanic Whites from the multi-ethnic Health & Aging Brain among Latino Elders (HABLE) study. Plasma NfL was measured on the Simoa platform. In unadjusted models, NfL was significantly associated with age (P < .001), hypertension (P  < .001), dyslipidemia (P = .02), and diabetes (P  < .001). Covarying for age and sex, NfL was associated with neurodegeneration (P  < .001) and global amyloid burden levels (P = .02) in a subset with available data. NfL levels were significantly associated with diagnostic groups (Normal Cognition [NC], mild cognitive impairment [MCI], Dementia; P  < .001); however, there was no cut-score that yielded acceptable diagnostic accuracy. NfL levels produced a sensitivity of 0.60 and specificity of 0.78 with negative predictive value of 89% for detecting amyloid positivity. Plasma NfL levels are significantly impacted by age and medical co-morbidities that are common among older adults, which complicate its utility as a diagnostic biomarker.

Identifiants

pubmed: 34310015
doi: 10.1002/alz.12404
pmc: PMC9228481
mid: NIHMS1779248
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-250

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066530
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB015922
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054073
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG058533
Pays : United States

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

PLoS One. 2011;6(12):e28092
pubmed: 22163278
Neurology. 2019 Jul 16;93(3):e252-e260
pubmed: 31182505
JAMA Neurol. 2017 May 1;74(5):557-566
pubmed: 28346578
Appl Neuropsychol Adult. 2015;22(4):252-61
pubmed: 25402323
Neurodegener Dis Manag. 2016 Jun;6(3):203-13
pubmed: 27229914
ACS Chem Neurosci. 2019 Aug 21;10(8):3479-3485
pubmed: 31145586
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Medicine (Baltimore). 2019 May;98(19):e15605
pubmed: 31083252
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimers Res Ther. 2018 Jul 28;10(1):71
pubmed: 30055655
Alzheimers Dement (Amst). 2015 Dec 29;3:27-34
pubmed: 27019866
Neurol Ther. 2017 Jul;6(Suppl 1):15-24
pubmed: 28733960
Alzheimers Dement. 2015 May;11(5):549-60
pubmed: 25282381
Psychopharmacol Bull. 1988;24(4):637-9
pubmed: 3249765
JAMA Neurol. 2019 Jul 1;76(7):791-799
pubmed: 31009028
Alzheimers Dement (Amst). 2019 Mar 15;11:270-276
pubmed: 30923734
JAMA Neurol. 2019 Mar 1;76(3):264-273
pubmed: 30615028
J Alzheimers Dis. 2021;79(2):671-681
pubmed: 33337378
J Alzheimers Dis. 2016 Jul 25;54(1):201-6
pubmed: 27472872
Alzheimers Res Ther. 2017 Nov 2;9(1):88
pubmed: 29096697
Dev Neuropsychol. 2018 Jan;43(1):1-26
pubmed: 29190120
Environ Health Perspect. 2002 Apr;110 Suppl 2:155-9
pubmed: 11929724
Alzheimers Dement (Amst). 2020 Jun 30;12(1):e12039
pubmed: 32626817
Alzheimers Dement (Amst). 2019 May 02;11:374-382
pubmed: 31080873
Ann Transl Med. 2019 Jul;7(Suppl 3):S133
pubmed: 31576340
Alzheimers Dement (Amst). 2019 Oct 22;11:700-709
pubmed: 31700989
Front Aging Neurosci. 2019 Sep 13;11:254
pubmed: 31572170
Alzheimers Dement. 2019 Feb;15(2):292-312
pubmed: 30555031
Neurobiol Aging. 2018 Oct;70:233-241
pubmed: 30036759
Clin Neuropsychol. 2002 Dec;16(4):439-51
pubmed: 12822053
J Alzheimers Dis. 2013;34(4):841-9
pubmed: 23313927
Alzheimers Dement. 2022 Feb;18(2):240-250
pubmed: 34310015
J Intern Med. 2018 Dec;284(6):643-663
pubmed: 30051512
Stroke. 2019 Jul;50(7):1669-1675
pubmed: 31138085
Alzheimers Dement (Amst). 2020 May 21;12(1):e12033
pubmed: 32490140
J Alzheimers Dis. 2021;79(1):59-70
pubmed: 33216030
Alzheimers Dement (Amst). 2016 Jun 25;3:83-90
pubmed: 27453929

Auteurs

Sid O'Bryant (S)

Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.

Melissa Petersen (M)

Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA.

James Hall (J)

Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA.

Leigh Johnson (L)

Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA.

Kristine Yaffe (K)

Department of Psychiatry, Neurology, and Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
San Francisco VA Medical Center, San Francisco, California, USA.

Meredith Braskie (M)

Imaging Genetics Center, Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, USC, Los Angeles, California, USA.

Arthur W Toga (AW)

Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, California, USA.

Robert A Rissman (RA)

Department of Neurosciences, University of California, San Diego, La Jolla, California, USA.
Veterans Affairs San Diego Healthcare System, San Diego, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH